25 XP   0   0   10

Charles River Laboratories
Buy, Hold or Sell?

Let's analyse Charles River Laboratories together

PenkeI guess you are interested in Charles River Laboratories. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Charles River Laboratories. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Charles River Laboratories

I send you an email if I find something interesting about Charles River Laboratories.

Quick analysis of Charles River Laboratories (30 sec.)










What can you expect buying and holding a share of Charles River Laboratories? (30 sec.)

How much money do you get?

How much money do you get?
$0.27
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$70.88
Expected worth in 1 year
$83.06
How sure are you?
87.5%

+ What do you gain per year?

Total Gains per Share
$12.45
Return On Investment
5.5%

For what price can you sell your share?

Current Price per Share
$227.55
Expected price per share
$166.87 - $275.00
How sure are you?
50%

1. Valuation of Charles River Laboratories (5 min.)




Live pricePrice per Share (EOD)

$227.55

Intrinsic Value Per Share

$70.88 - $166.49

Total Value Per Share

$141.76 - $237.37

2. Growth of Charles River Laboratories (5 min.)




Is Charles River Laboratories growing?

Current yearPrevious yearGrowGrow %
How rich?$3.6b$2.7b$601.8m17.9%

How much money is Charles River Laboratories making?

Current yearPrevious yearGrowGrow %
Making money$118.6m$121.5m-$2.9m-2.4%
Net Profit Margin11.5%12.1%--

How much money comes from the company's main activities?

3. Financial Health of Charles River Laboratories (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#16 / 146

Most Revenue
#20 / 146

Most Profit
#23 / 146

What can you expect buying and holding a share of Charles River Laboratories? (5 min.)

Welcome investor! Charles River Laboratories's management wants to use your money to grow the business. In return you get a share of Charles River Laboratories.

What can you expect buying and holding a share of Charles River Laboratories?

First you should know what it really means to hold a share of Charles River Laboratories. And how you can make/lose money.

Speculation

The Price per Share of Charles River Laboratories is $227.55. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Charles River Laboratories.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Charles River Laboratories, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $70.88. Based on the TTM, the Book Value Change Per Share is $3.05 per quarter. Based on the YOY, the Book Value Change Per Share is $2.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Charles River Laboratories.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps3.621.6%2.301.0%2.361.0%1.910.8%1.330.6%
Usd Book Value Change Per Share5.952.6%3.051.3%2.110.9%2.241.0%1.450.6%
Usd Dividend Per Share0.120.1%0.070.0%0.010.0%0.020.0%0.010.0%
Usd Total Gains Per Share6.072.7%3.111.4%2.120.9%2.261.0%1.460.6%
Usd Price Per Share236.40-211.11-228.16-227.77-156.99-
Price to Earnings Ratio16.31-24.59-26.44-32.25-27.19-
Price-to-Total Gains Ratio38.97-99.80-43.04-117.97-112.34-
Price to Book Ratio3.34-3.23-4.27-5.06-4.97-
Price-to-Total Gains Ratio38.97-99.80-43.04-117.97-112.34-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share227.55
Number of shares4
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.070.02
Usd Book Value Change Per Share3.052.24
Usd Total Gains Per Share3.112.26
Gains per Quarter (4 shares)12.459.04
Gains per Year (4 shares)49.8036.16
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11494003626
22979007262
33146140110898
441951901144134
552442401180170
662922901216206
773413402251242
893903902287278
9104394402323314
10114874902359350

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.01.00.097.5%91.05.00.094.8%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%35.05.00.087.5%76.020.00.079.2%
Dividend per Share3.00.01.075.0%4.00.08.033.3%4.00.016.020.0%4.00.036.010.0%15.00.081.015.6%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%35.05.00.087.5%76.020.00.079.2%

Fundamentals of Charles River Laboratories

About Charles River Laboratories

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-13 10:34:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Charles River Laboratories.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Charles River Laboratories earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Charles River Laboratories to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 18.5% means that $0.18 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Charles River Laboratories:

  • The MRQ is 18.5%. The company is making a huge profit. +2
  • The TTM is 11.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ18.5%TTM11.5%+6.9%
TTM11.5%YOY12.1%-0.5%
TTM11.5%5Y11.3%+0.3%
5Y11.3%10Y10.3%+1.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ18.5%-7.2%+25.7%
TTM11.5%-6.3%+17.8%
YOY12.1%1.3%+10.8%
5Y11.3%-2.2%+13.5%
10Y10.3%-1.4%+11.7%
1.1.2. Return on Assets

Shows how efficient Charles River Laboratories is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Charles River Laboratories to the Diagnostics & Research industry mean.
  • 2.3% Return on Assets means that Charles River Laboratories generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Charles River Laboratories:

  • The MRQ is 2.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.3%TTM1.5%+0.8%
TTM1.5%YOY1.6%-0.1%
TTM1.5%5Y1.5%0.0%
5Y1.5%10Y1.6%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3%-1.5%+3.8%
TTM1.5%-1.2%+2.7%
YOY1.6%-0.6%+2.2%
5Y1.5%-0.6%+2.1%
10Y1.6%-0.9%+2.5%
1.1.3. Return on Equity

Shows how efficient Charles River Laboratories is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Charles River Laboratories to the Diagnostics & Research industry mean.
  • 5.2% Return on Equity means Charles River Laboratories generated $0.05 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Charles River Laboratories:

  • The MRQ is 5.2%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 3.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ5.2%TTM3.5%+1.7%
TTM3.5%YOY4.4%-0.9%
TTM3.5%5Y4.2%-0.7%
5Y4.2%10Y4.4%-0.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ5.2%-0.5%+5.7%
TTM3.5%-+3.5%
YOY4.4%0.3%+4.1%
5Y4.2%-1.5%+5.7%
10Y4.4%-2.5%+6.9%

1.2. Operating Efficiency of Charles River Laboratories.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Charles River Laboratories is operating .

  • Measures how much profit Charles River Laboratories makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Charles River Laboratories to the Diagnostics & Research industry mean.
  • An Operating Margin of 23.9% means the company generated $0.24  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Charles River Laboratories:

  • The MRQ is 23.9%. The company is operating efficient. +1
  • The TTM is 17.5%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ23.9%TTM17.5%+6.4%
TTM17.5%YOY18.0%-0.6%
TTM17.5%5Y16.6%+0.9%
5Y16.6%10Y16.1%+0.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ23.9%-6.2%+30.1%
TTM17.5%-5.8%+23.3%
YOY18.0%4.8%+13.2%
5Y16.6%1.6%+15.0%
10Y16.1%-2.0%+18.1%
1.2.2. Operating Ratio

Measures how efficient Charles River Laboratories is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.87 means that the operating costs are $0.87 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Charles River Laboratories:

  • The MRQ is 0.869. The company is less efficient in keeping operating costs low.
  • The TTM is 0.851. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.869TTM0.851+0.018
TTM0.851YOY0.836+0.015
TTM0.8515Y0.848+0.003
5Y0.84810Y0.851-0.003
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8691.310-0.441
TTM0.8511.303-0.452
YOY0.8361.240-0.404
5Y0.8481.270-0.422
10Y0.8511.228-0.377

1.3. Liquidity of Charles River Laboratories.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Charles River Laboratories is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.52 means the company has $1.52 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Charles River Laboratories:

  • The MRQ is 1.525. The company is able to pay all its short-term debts. +1
  • The TTM is 1.487. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.525TTM1.487+0.038
TTM1.487YOY1.346+0.141
TTM1.4875Y1.476+0.011
5Y1.47610Y1.690-0.214
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5252.194-0.669
TTM1.4872.366-0.879
YOY1.3462.753-1.407
5Y1.4762.989-1.513
10Y1.6903.000-1.310
1.3.2. Quick Ratio

Measures if Charles River Laboratories is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Charles River Laboratories to the Diagnostics & Research industry mean.
  • A Quick Ratio of 1.00 means the company can pay off $1.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Charles River Laboratories:

  • The MRQ is 1.002. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.992. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.002TTM0.992+0.010
TTM0.992YOY0.932+0.061
TTM0.9925Y1.040-0.048
5Y1.04010Y1.221-0.181
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0021.273-0.271
TTM0.9921.355-0.363
YOY0.9321.563-0.631
5Y1.0401.952-0.912
10Y1.2212.127-0.906

1.4. Solvency of Charles River Laboratories.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Charles River Laboratories assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Charles River Laboratories to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.55 means that Charles River Laboratories assets are financed with 55.4% credit (debt) and the remaining percentage (100% - 55.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Charles River Laboratories:

  • The MRQ is 0.554. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.570. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.554TTM0.570-0.016
TTM0.570YOY0.626-0.057
TTM0.5705Y0.627-0.057
5Y0.62710Y0.633-0.007
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5540.425+0.129
TTM0.5700.411+0.159
YOY0.6260.393+0.233
5Y0.6270.450+0.177
10Y0.6330.448+0.185
1.4.2. Debt to Equity Ratio

Measures if Charles River Laboratories is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Charles River Laboratories to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 126.1% means that company has $1.26 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Charles River Laboratories:

  • The MRQ is 1.261. The company is able to pay all its debts with equity. +1
  • The TTM is 1.346. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.261TTM1.346-0.085
TTM1.346YOY1.711-0.365
TTM1.3465Y1.730-0.384
5Y1.73010Y1.791-0.061
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2610.606+0.655
TTM1.3460.571+0.775
YOY1.7110.606+1.105
5Y1.7300.637+1.093
10Y1.7910.730+1.061

2. Market Valuation of Charles River Laboratories

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Charles River Laboratories generates.

  • Above 15 is considered overpriced but always compare Charles River Laboratories to the Diagnostics & Research industry mean.
  • A PE ratio of 16.31 means the investor is paying $16.31 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Charles River Laboratories:

  • The EOD is 15.698. Based on the earnings, the company is fair priced.
  • The MRQ is 16.308. Based on the earnings, the company is fair priced.
  • The TTM is 24.587. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD15.698MRQ16.308-0.611
MRQ16.308TTM24.587-8.279
TTM24.587YOY26.440-1.853
TTM24.5875Y32.254-7.667
5Y32.25410Y27.191+5.063
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD15.698-0.202+15.900
MRQ16.308-0.402+16.710
TTM24.587-0.119+24.706
YOY26.440-0.003+26.443
5Y32.2542.211+30.043
10Y27.1914.907+22.284
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Charles River Laboratories:

  • The EOD is 20.592. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 21.392. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 277.332. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD20.592MRQ21.392-0.801
MRQ21.392TTM277.332-255.939
TTM277.332YOY66.890+210.442
TTM277.3325Y35.282+242.050
5Y35.28210Y117.052-81.770
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD20.592-0.179+20.771
MRQ21.392-0.417+21.809
TTM277.332-1.288+278.620
YOY66.890-2.547+69.437
5Y35.282-1.999+37.281
10Y117.052-2.372+119.424
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Charles River Laboratories is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 3.34 means the investor is paying $3.34 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Charles River Laboratories:

  • The EOD is 3.210. Based on the equity, the company is fair priced.
  • The MRQ is 3.335. Based on the equity, the company is fair priced.
  • The TTM is 3.232. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.210MRQ3.335-0.125
MRQ3.335TTM3.232+0.103
TTM3.232YOY4.269-1.037
TTM3.2325Y5.061-1.829
5Y5.06110Y4.971+0.090
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD3.2101.877+1.333
MRQ3.3352.437+0.898
TTM3.2322.235+0.997
YOY4.2693.239+1.030
5Y5.0613.450+1.611
10Y4.9714.040+0.931
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Charles River Laboratories.

3.1. Institutions holding Charles River Laboratories

Institutions are holding 102.983% of the shares of Charles River Laboratories.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc11.60980.03095980306264460.4442
2023-12-31BlackRock Inc10.020.03115161360407930.7967
2023-12-31State Street Corporation3.99870.02372059785339851.6776
2023-12-31Kayne Anderson Rudnick Investment Management LLC3.40361.037175323871370.4087
2023-12-31ClearBridge Advisors, LLC2.850.29861468059-277935-15.9184
2023-12-31T. Rowe Price Associates, Inc.2.80170.04581443175-237498-14.1311
2023-12-31Allspring Global Investments Holdings, LLC2.26230.45671165306-29920-2.5033
2023-12-31Meritage Group LP2.2436.2879115537627174330.7529
2023-12-31Geode Capital Management, LLC2.22480.02831146009231862.065
2023-12-31Ariel Investments, LLC2.03982.47331050698-15902-1.4909
2023-12-31Southpoint Capital Advisors LP1.94135.0784100000020000025
2023-12-31Amvescap Plc.1.8410.0534948318204232.201
2023-12-31Mackenzie Investments1.78190.3273917858-5791-0.627
2023-12-31Earnest Partners LLC1.72661.04988893688348510.3594
2023-12-31Franklin Resources Inc1.48130.0843763015-18486-2.3654
2023-12-31Bank of America Corp1.4290.0175736108-50951-6.4736
2023-12-31Montrusco Bolton Investments Inc1.40182.0761722091-133296-15.5831
2023-12-31Fidelity International Ltd1.28640.164666265012500023.2493
2023-12-31SEI Investments Co1.10310.215656820711049424.1405
2023-12-31Wells Fargo & Co1.0590.0336545525-27223-4.7531
Total 58.505119.813930136452+145690+0.5%

3.2. Funds holding Charles River Laboratories

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv3.12220.02641608275-3405-0.2113
2024-02-29Vanguard Small Cap Index2.56770.23921322632134161.0247
2024-02-29Vanguard Institutional 500 Index Trust2.48750.03051281351136181.0742
2023-12-31Allspring Special US Mid Cap Value Eq1.89231.8354974714-7900-0.804
2024-02-29Allspring Special Mid Cap Value Inst1.81861.8628936764-37950-3.8934
2024-02-29BlackRock Mid-Cap Growth Equity Instl1.58131.6347814529-51349-5.9303
2024-02-29Vanguard Small Cap Growth Index Inv1.44020.5404741869113171.5491
2024-03-28SPDR® S&P 500 ETF Trust1.20390.031362013036000.5839
2024-02-29Fidelity 500 Index1.19440.030461522961911.0165
2023-12-31T. Rowe Price US Mid-Cap Value Equity1.18041.0441608012-123490-16.8817
2023-12-31T. Rowe Price Mid-Cap Value1.18041.0461608012-123490-16.8817
2023-12-31Fidelity Small Cap America Sr B1.05356.776154264900
2024-03-28iShares Core S&P 500 ETF1.03260.031553192139680.7516
2024-01-31Canada Life US Small-Mid Cap Growth A0.79914.042441162500
2024-03-28Invesco S&P 500® Equal Weight ETF0.77250.19793979309600.2418
2024-03-28Health Care Select Sector SPDR® ETF0.75150.254387100-621-0.1602
2024-03-28iShares Biotechnology ETF0.7321.3388377046-657-0.1739
2024-02-29Vanguard Institutional Index I0.65540.0303337581-1970-0.5802
2024-02-29NBI US Equity Priv Ptf F CAD0.64632.92163329316415523.8693
2023-12-31Victory Small Cap Value CIT (Net 75)0.63871.10583290005800021.4022
Total 26.750525.019713779300-175607-1.3%

3.3. Insider Transactions

Insiders are holding 0.979% of the shares of Charles River Laboratories.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-29Victoria L CreamerSELL5000253.7
2024-02-22William D BarboSELL4050248.5
2024-02-15Shannon M ParisottoSELL5882241.2
2023-11-20Birgit GirshickBUY1322187.82
2023-11-14James C FosterBUY5620178.05
2023-08-24Richard F WallmanBUY1000198.79
2023-08-10Joseph W LaplumeSELL700216.52
2023-08-10Michael Gunnar KnellSELL1471216.54
2023-08-10William D BarboSELL5763217.24
2023-05-15Joseph W LaplumeSELL345190.39

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Charles River Laboratories compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--5.9503.045+95%2.105+183%2.245+165%1.449+311%
Book Value Per Share--70.87865.289+9%53.675+32%46.393+53%31.994+122%
Current Ratio--1.5251.487+3%1.346+13%1.476+3%1.690-10%
Debt To Asset Ratio--0.5540.570-3%0.626-12%0.627-12%0.633-13%
Debt To Equity Ratio--1.2611.346-6%1.711-26%1.730-27%1.791-30%
Dividend Per Share--0.1150.067+72%0.010+1008%0.015+644%0.008+1389%
Eps--3.6242.301+58%2.360+54%1.910+90%1.335+172%
Free Cash Flow Per Share--2.7631.770+56%1.431+93%1.856+49%1.508+83%
Free Cash Flow To Equity Per Share--5.1561.356+280%1.226+321%2.656+94%2.299+124%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--166.492--------
Intrinsic Value_10Y_min--70.884--------
Intrinsic Value_1Y_max--9.022--------
Intrinsic Value_1Y_min--6.254--------
Intrinsic Value_3Y_max--32.946--------
Intrinsic Value_3Y_min--19.637--------
Intrinsic Value_5Y_max--63.911--------
Intrinsic Value_5Y_min--33.846--------
Market Cap11721282540.000-4%12203913600.00010885977204.000+12%11752704128.000+4%11736805210.400+4%8088492329.800+51%
Net Profit Margin--0.1850.115+60%0.121+53%0.113+64%0.103+79%
Operating Margin--0.2390.175+37%0.180+32%0.166+44%0.161+48%
Operating Ratio--0.8690.851+2%0.836+4%0.848+2%0.851+2%
Pb Ratio3.210-4%3.3353.232+3%4.269-22%5.061-34%4.971-33%
Pe Ratio15.698-4%16.30824.587-34%26.440-38%32.254-49%27.191-40%
Price Per Share227.550-4%236.400211.113+12%228.160+4%227.772+4%156.986+51%
Price To Free Cash Flow Ratio20.592-4%21.392277.332-92%66.890-68%35.282-39%117.052-82%
Price To Total Gains Ratio37.516-4%38.97599.796-61%43.041-9%117.974-67%112.343-65%
Quick Ratio--1.0020.992+1%0.932+8%1.040-4%1.221-18%
Return On Assets--0.0230.015+52%0.016+40%0.015+48%0.016+46%
Return On Equity--0.0520.035+47%0.044+18%0.042+24%0.044+19%
Total Gains Per Share--6.0653.112+95%2.115+187%2.260+168%1.457+316%
Usd Book Value--3658998000.0003366631750.000+9%2764819500.000+32%2390687750.000+53%1648518750.000+122%
Usd Book Value Change Per Share--5.9503.045+95%2.105+183%2.245+165%1.449+311%
Usd Book Value Per Share--70.87865.289+9%53.675+32%46.393+53%31.994+122%
Usd Dividend Per Share--0.1150.067+72%0.010+1008%0.015+644%0.008+1389%
Usd Eps--3.6242.301+58%2.360+54%1.910+90%1.335+172%
Usd Free Cash Flow--142620000.00091342500.000+56%73726750.000+93%95637050.000+49%77698100.000+84%
Usd Free Cash Flow Per Share--2.7631.770+56%1.431+93%1.856+49%1.508+83%
Usd Free Cash Flow To Equity Per Share--5.1561.356+280%1.226+321%2.656+94%2.299+124%
Usd Market Cap11721282540.000-4%12203913600.00010885977204.000+12%11752704128.000+4%11736805210.400+4%8088492329.800+51%
Usd Price Per Share227.550-4%236.400211.113+12%228.160+4%227.772+4%156.986+51%
Usd Profit--187084000.000118656000.000+58%121556500.000+54%98407750.000+90%68716475.000+172%
Usd Revenue--1013476000.0001032352250.000-2%994015000.000+2%859539400.000+18%641422025.000+58%
Usd Total Gains Per Share--6.0653.112+95%2.115+187%2.260+168%1.457+316%
 EOD+4 -4MRQTTM+30 -5YOY+32 -35Y+31 -410Y+30 -5

4.2. Fundamental Score

Let's check the fundamental score of Charles River Laboratories based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1515.698
Price to Book Ratio (EOD)Between0-13.210
Net Profit Margin (MRQ)Greater than00.185
Operating Margin (MRQ)Greater than00.239
Quick Ratio (MRQ)Greater than11.002
Current Ratio (MRQ)Greater than11.525
Debt to Asset Ratio (MRQ)Less than10.554
Debt to Equity Ratio (MRQ)Less than11.261
Return on Equity (MRQ)Greater than0.150.052
Return on Assets (MRQ)Greater than0.050.023
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Charles River Laboratories based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.954
Ma 20Greater thanMa 50254.211
Ma 50Greater thanMa 100252.066
Ma 100Greater thanMa 200234.383
OpenGreater thanClose228.020
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Total Other Income Expense Net -34,779-2,072-36,85134,188-2,663-3,597-6,260113,997107,737



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets8,195,001
Total Liabilities4,536,003
Total Stockholder Equity3,596,882
 As reported
Total Liabilities 4,536,003
Total Stockholder Equity+ 3,596,882
Total Assets = 8,195,001

Assets

Total Assets8,195,001
Total Current Assets1,608,662
Long-term Assets6,586,339
Total Current Assets
Cash And Cash Equivalents 276,771
Net Receivables 780,375
Inventory 380,259
Other Current Assets 83,378
Total Current Assets  (as reported)1,608,662
Total Current Assets  (calculated)1,520,783
+/- 87,879
Long-term Assets
Property Plant Equipment 2,033,770
Goodwill 3,095,045
Long Term Investments 243,811
Intangible Assets 864,051
Long-term Assets Other 309,383
Long-term Assets  (as reported)6,586,339
Long-term Assets  (calculated)6,546,060
+/- 40,279

Liabilities & Shareholders' Equity

Total Current Liabilities1,055,082
Long-term Liabilities3,480,921
Total Stockholder Equity3,596,882
Total Current Liabilities
Short-term Debt 441,115
Accounts payable 168,937
Other Current Liabilities 203,210
Total Current Liabilities  (as reported)1,055,082
Total Current Liabilities  (calculated)813,262
+/- 241,820
Long-term Liabilities
Long term Debt 2,647,147
Capital Lease Obligations 419,234
Long-term Liabilities Other 223,191
Long-term Liabilities  (as reported)3,480,921
Long-term Liabilities  (calculated)3,289,572
+/- 191,349
Total Stockholder Equity
Common Stock513
Retained Earnings 1,887,218
Accumulated Other Comprehensive Income -196,427
Other Stockholders Equity 1,905,578
Total Stockholder Equity (as reported)3,596,882
Total Stockholder Equity (calculated)3,596,882
+/-0
Other
Capital Stock513
Cash and Short Term Investments 276,771
Common Stock Shares Outstanding 51,624
Current Deferred Revenue241,820
Liabilities and Stockholders Equity 8,195,001
Net Debt 2,789,610
Net Invested Capital 6,244,029
Net Working Capital 553,580
Property Plant and Equipment Gross 3,369,079
Short Long Term Debt Total 3,066,381



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
401,600
398,900
409,122
410,608
555,385
516,795
586,070
571,362
664,192
629,880
656,308
701,344
706,140
737,069
765,152
799,554
825,826
862,384
907,048
2,626,835
2,627,016
2,548,007
2,589,395
2,538,209
2,410,424
2,617,086
2,503,215
2,557,544
2,568,394
2,664,079
2,735,774
2,805,537
2,844,727
2,891,098
2,896,882
2,159,918
2,087,588
2,153,618
2,191,532
2,204,093
2,186,871
2,156,637
2,080,273
1,733,373
1,744,620
1,705,425
1,585,373
1,558,320
1,555,358
1,546,073
1,567,618
1,586,344
1,603,808
1,621,598
1,643,767
1,644,621
1,651,763
1,863,462
1,842,358
1,885,192
1,847,229
1,885,917
2,032,843
2,068,497
2,103,718
2,762,987
2,690,190
2,711,800
2,697,075
2,773,664
2,865,918
2,929,922
3,001,003
3,865,883
3,796,657
3,855,879
3,926,637
4,625,484
4,582,562
4,692,790
5,201,790
5,240,884
5,213,338
5,490,831
5,808,963
6,720,352
7,058,437
7,024,292
7,075,049
7,529,361
7,382,769
7,602,770
7,699,439
7,772,381
7,607,007
8,195,001
8,195,0017,607,0077,772,3817,699,4397,602,7707,382,7697,529,3617,075,0497,024,2927,058,4376,720,3525,808,9635,490,8315,213,3385,240,8845,201,7904,692,7904,582,5624,625,4843,926,6373,855,8793,796,6573,865,8833,001,0032,929,9222,865,9182,773,6642,697,0752,711,8002,690,1902,762,9872,103,7182,068,4972,032,8431,885,9171,847,2291,885,1921,842,3581,863,4621,651,7631,644,6211,643,7671,621,5981,603,8081,586,3441,567,6181,546,0731,555,3581,558,3201,585,3731,705,4251,744,6201,733,3732,080,2732,156,6372,186,8712,204,0932,191,5322,153,6182,087,5882,159,9182,896,8822,891,0982,844,7272,805,5372,735,7742,664,0792,568,3942,557,5442,503,2152,617,0862,410,4242,538,2092,589,3952,548,0072,627,0162,626,835907,048862,384825,826799,554765,152737,069706,140701,344656,308629,880664,192571,362586,070516,795555,385410,608409,122398,900401,600
   > Total Current Assets 
111,774
108,338
114,275
119,737
195,202
161,655
224,582
210,154
294,137
239,708
273,920
278,092
286,190
314,877
346,091
370,888
386,369
424,610
465,360
510,306
522,992
479,279
498,767
419,322
412,659
526,383
559,730
501,093
482,239
527,547
555,345
607,864
646,089
676,940
618,825
618,139
581,720
569,705
566,363
595,601
613,741
608,048
527,297
552,894
560,584
548,252
456,329
425,843
437,270
451,559
457,915
485,252
492,619
519,757
547,781
552,550
590,658
592,702
606,019
606,898
614,142
629,647
578,661
559,234
637,391
701,547
654,578
656,832
700,121
738,067
782,378
826,625
843,348
889,530
838,166
897,836
866,182
1,010,058
972,407
1,021,325
1,208,281
1,234,725
1,140,274
1,201,131
1,423,209
1,267,913
1,379,040
1,274,095
1,333,086
1,393,086
1,415,352
1,439,032
1,448,355
1,504,780
1,444,325
1,608,662
1,608,6621,444,3251,504,7801,448,3551,439,0321,415,3521,393,0861,333,0861,274,0951,379,0401,267,9131,423,2091,201,1311,140,2741,234,7251,208,2811,021,325972,4071,010,058866,182897,836838,166889,530843,348826,625782,378738,067700,121656,832654,578701,547637,391559,234578,661629,647614,142606,898606,019592,702590,658552,550547,781519,757492,619485,252457,915451,559437,270425,843456,329548,252560,584552,894527,297608,048613,741595,601566,363569,705581,720618,139618,825676,940646,089607,864555,345527,547482,239501,093559,730526,383412,659419,322498,767479,279522,992510,306465,360424,610386,369370,888346,091314,877286,190278,092273,920239,708294,137210,154224,582161,655195,202119,737114,275108,338111,774
       Cash And Cash Equivalents 
18,458
18,993
28,008
33,129
72,399
28,416
78,303
58,271
135,398
84,712
112,389
122,509
114,014
144,341
164,316
182,331
189,746
224,153
259,406
207,566
213,059
166,549
167,705
114,821
101,456
193,067
253,504
175,380
136,537
162,050
183,497
225,449
239,876
262,438
212,851
243,592
170,233
154,806
192,198
182,574
222,199
219,077
137,433
179,160
158,745
145,831
81,220
68,905
61,031
76,076
83,224
109,685
100,422
113,521
130,454
155,927
169,850
117,012
130,747
160,023
151,919
150,807
74,032
117,947
157,375
154,585
105,722
117,626
131,524
116,466
123,618
163,794
187,774
192,300
138,866
195,442
126,316
200,589
164,759
238,014
372,433
402,020
242,879
228,424
465,411
222,969
212,539
241,214
241,869
200,321
193,701
233,912
201,587
200,445
157,174
276,771
276,771157,174200,445201,587233,912193,701200,321241,869241,214212,539222,969465,411228,424242,879402,020372,433238,014164,759200,589126,316195,442138,866192,300187,774163,794123,618116,466131,524117,626105,722154,585157,375117,94774,032150,807151,919160,023130,747117,012169,850155,927130,454113,521100,422109,68583,22476,07661,03168,90581,220145,831158,745179,160137,433219,077222,199182,574192,198154,806170,233243,592212,851262,438239,876225,449183,497162,050136,537175,380253,504193,067101,456114,821167,705166,549213,059207,566259,406224,153189,746182,331164,316144,341114,014122,509112,38984,712135,39858,27178,30328,41672,39933,12928,00818,99318,458
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
5,000
0
0
11,192
13,156
13,301
10,506
10,857
234
1,435
200
1,500
1,677
1,486
7,672
7,309
7,450
6,927
3,330
6,481
14,958
8,344
3,295
3,224
2,725
36,000
50,300
6,900
56,436
11,500
17,200
14,200
9,834
14,500
11,800
6,200
5,359
6,365
6,852
6,400
6,781
6,846
6,929
11,084
11,158
11,446
11,855
14,577
16,167
14,906
18,074
17,975
20,516
18,846
25,046
7,734
3,771
3,872
23,476
30,351
28,489
2,542
903
5,238
885
907
887
855
941
934
929
963
1,024
1,025
1,037
1,030
1,063
1,065
1,012
950
998
1,001
951
944
0
09449511,0019989501,0121,0651,0631,0301,0371,0251,0249639299349418558879078855,2389032,54228,48930,35123,4763,8723,7717,73425,04618,84620,51617,97518,07414,90616,16714,57711,85511,44611,15811,0846,9296,8466,7816,4006,8526,3655,3596,20011,80014,5009,83414,20017,20011,50056,4366,90050,30036,0002,7253,2243,2958,34414,9586,4813,3306,9277,4507,3097,6721,4861,6771,5002001,43523410,85710,50613,30113,15611,192005,00000000000000
       Net Receivables 
53,022
50,930
48,294
45,949
78,378
87,354
98,021
98,478
105,127
99,829
98,718
94,245
105,811
106,472
105,653
111,514
119,916
124,978
128,601
201,794
204,912
210,308
210,155
203,274
201,069
177,555
185,275
202,658
210,166
228,622
232,041
213,908
239,385
240,009
237,268
210,214
211,095
209,888
212,872
196,947
219,676
218,695
216,740
192,972
215,304
212,422
202,379
184,810
205,893
208,046
215,621
203,001
213,540
224,030
224,270
220,630
239,998
274,504
275,024
257,991
265,426
277,398
288,836
270,068
287,178
345,539
359,734
364,050
383,748
398,547
422,335
430,016
440,109
478,735
487,339
472,248
495,501
545,148
524,074
514,033
542,390
532,531
572,058
617,740
610,566
644,027
660,452
642,881
706,796
747,605
778,499
752,390
788,309
800,646
799,310
780,375
780,375799,310800,646788,309752,390778,499747,605706,796642,881660,452644,027610,566617,740572,058532,531542,390514,033524,074545,148495,501472,248487,339478,735440,109430,016422,335398,547383,748364,050359,734345,539287,178270,068288,836277,398265,426257,991275,024274,504239,998220,630224,270224,030213,540203,001215,621208,046205,893184,810202,379212,422215,304192,972216,740218,695219,676196,947212,872209,888211,095210,214237,268240,009239,385213,908232,041228,622210,166202,658185,275177,555201,069203,274210,155210,308204,912201,794128,601124,978119,916111,514105,653106,472105,81194,24598,71899,829105,12798,47898,02187,35478,37845,94948,29450,93053,022
       Inventory 
32,462
32,192
31,544
33,890
34,287
36,607
39,206
39,056
39,125
39,454
41,921
43,892
45,564
46,844
48,541
52,370
53,050
54,676
55,572
61,914
63,680
60,373
65,021
65,270
68,167
69,036
71,821
72,362
75,681
77,169
80,234
88,023
90,881
93,602
93,537
96,882
97,560
96,403
100,290
102,723
97,578
96,571
100,759
100,297
97,594
100,533
94,391
92,969
89,347
92,283
93,718
88,470
84,959
88,405
87,146
89,396
91,674
92,621
92,695
89,043
86,055
90,037
98,097
93,735
97,101
98,116
99,374
95,833
98,482
104,690
107,372
114,956
119,046
124,131
125,500
127,892
129,765
134,925
155,526
160,660
162,938
168,366
181,367
185,695
193,584
194,341
181,694
199,146
221,175
256,765
261,522
255,809
262,584
285,280
292,972
380,259
380,259292,972285,280262,584255,809261,522256,765221,175199,146181,694194,341193,584185,695181,367168,366162,938160,660155,526134,925129,765127,892125,500124,131119,046114,956107,372104,69098,48295,83399,37498,11697,10193,73598,09790,03786,05589,04392,69592,62191,67489,39687,14688,40584,95988,47093,71892,28389,34792,96994,391100,53397,594100,297100,75996,57197,578102,723100,29096,40397,56096,88293,53793,60290,88188,02380,23477,16975,68172,36271,82169,03668,16765,27065,02160,37363,68061,91455,57254,67653,05052,37048,54146,84445,56443,89241,92139,45439,12539,05639,20636,60734,28733,89031,54432,19232,462
       Other Current Assets 
7,832
6,223
6,429
6,769
8,083
7,223
6,997
14,349
5,786
15,700
20,900
12,446
15,801
17,220
16,389
11,517
10,356
10,297
10,924
38,798
39,906
42,049
55,886
34,280
40,481
44,179
2,741
6,330
5,669
1,123
1,414
3,226
2,500
563
575
233
102,832
108,608
61,003
56,921
74,288
73,705
72,365
3,862
87,863
89,194
78,339
73,800
80,892
75,047
65,243
83,601
92,993
86,872
105,153
85,847
77,690
96,710
106,718
99,841
110,742
1,684
923
47,286
148
148
148
45,008
82,495
94,888
98,702
81,315
93,877
300
300
48,807
500
618
366
56,030
300
307
300
72,560
152,623
121,966
323,325
97,311
162,181
107,456
180,680
107,580
91,713
113,389
93,314
83,378
83,37893,314113,38991,713107,580180,680107,456162,18197,311323,325121,966152,62372,56030030730056,03036661850048,80730030093,87781,31598,70294,88882,49545,00814814814847,2869231,684110,74299,841106,71896,71077,69085,847105,15386,87292,99383,60165,24375,04780,89273,80078,33989,19487,8633,86272,36573,70574,28856,92161,003108,608102,8322335755632,5003,2261,4141,1235,6696,3302,74144,17940,48134,28055,88642,04939,90638,79810,92410,29710,35611,51716,38917,22015,80112,44620,90015,7005,78614,3496,9977,2238,0836,7696,4296,2237,832
   > Long-term Assets 
289,826
290,562
294,847
290,871
360,183
355,140
361,488
361,208
370,055
390,172
382,388
423,252
419,950
422,192
419,061
428,666
439,457
437,774
441,688
2,116,529
2,104,024
2,068,728
2,090,628
2,118,887
1,997,765
2,090,703
1,943,485
2,056,451
2,086,155
2,136,532
2,180,429
2,197,673
2,198,638
2,214,158
2,278,057
1,541,779
1,505,868
1,583,913
1,625,169
1,608,492
1,573,130
1,548,589
1,552,976
1,180,479
1,184,036
1,157,173
1,129,044
1,132,477
1,118,088
1,094,514
1,109,703
1,101,092
1,111,189
1,101,841
1,095,986
1,092,071
1,061,105
1,270,760
1,236,339
1,278,294
1,233,087
1,256,270
1,454,182
1,509,263
1,466,327
2,061,440
2,035,612
2,054,968
1,996,954
2,035,597
2,083,540
2,103,297
2,157,655
2,976,353
2,958,491
2,958,043
3,060,455
3,615,426
3,610,155
3,671,465
3,993,509
4,006,159
4,073,064
4,289,700
4,385,754
5,452,439
5,679,397
5,750,197
5,741,963
6,136,275
5,967,416
6,163,738
6,251,084
6,267,601
6,162,682
6,586,339
6,586,3396,162,6826,267,6016,251,0846,163,7385,967,4166,136,2755,741,9635,750,1975,679,3975,452,4394,385,7544,289,7004,073,0644,006,1593,993,5093,671,4653,610,1553,615,4263,060,4552,958,0432,958,4912,976,3532,157,6552,103,2972,083,5402,035,5971,996,9542,054,9682,035,6122,061,4401,466,3271,509,2631,454,1821,256,2701,233,0871,278,2941,236,3391,270,7601,061,1051,092,0711,095,9861,101,8411,111,1891,101,0921,109,7031,094,5141,118,0881,132,4771,129,0441,157,1731,184,0361,180,4791,552,9761,548,5891,573,1301,608,4921,625,1691,583,9131,505,8681,541,7792,278,0572,214,1582,198,6382,197,6732,180,4292,136,5322,086,1552,056,4511,943,4852,090,7031,997,7652,118,8872,090,6282,068,7282,104,0242,116,529441,688437,774439,457428,666419,061422,192419,950423,252382,388390,172370,055361,208361,488355,140360,183290,871294,847290,562289,826
       Property Plant Equipment 
119,174
117,741
114,684
117,001
139,694
141,807
149,249
155,919
153,901
169,088
174,548
187,875
184,736
194,615
193,003
203,458
207,309
205,885
209,193
357,149
360,943
349,623
386,310
399,454
428,004
440,348
460,856
534,745
566,145
622,492
688,150
748,793
788,218
826,835
845,130
828,921
834,545
857,517
863,786
865,743
848,322
837,580
838,559
752,657
753,612
743,450
728,887
738,030
740,225
727,405
724,699
717,020
707,053
696,495
690,725
676,182
665,609
687,664
671,244
676,797
657,601
680,565
671,673
677,959
664,437
783,678
767,177
755,827
746,951
758,724
767,192
781,973
788,554
896,273
896,901
932,877
1,038,071
1,138,210
1,148,406
1,184,213
1,188,977
1,197,197
1,205,591
1,302,578
1,314,671
1,465,940
1,460,633
1,584,009
1,626,376
1,765,543
1,753,978
1,857,417
1,902,544
1,926,832
1,900,807
2,033,770
2,033,7701,900,8071,926,8321,902,5441,857,4171,753,9781,765,5431,626,3761,584,0091,460,6331,465,9401,314,6711,302,5781,205,5911,197,1971,188,9771,184,2131,148,4061,138,2101,038,071932,877896,901896,273788,554781,973767,192758,724746,951755,827767,177783,678664,437677,959671,673680,565657,601676,797671,244687,664665,609676,182690,725696,495707,053717,020724,699727,405740,225738,030728,887743,450753,612752,657838,559837,580848,322865,743863,786857,517834,545828,921845,130826,835788,218748,793688,150622,492566,145534,745460,856440,348428,004399,454386,310349,623360,943357,149209,193205,885207,309203,458193,003194,615184,736187,875174,548169,088153,901155,919149,249141,807139,694117,001114,684117,741119,174
       Goodwill 
0
41,700
40,500
41,900
41,900
0
90,984
52,100
70,430
87,416
78,700
96,500
105,118
104,270
103,600
105,300
114,165
113,691
115,000
1,422,600
1,419,762
1,419,100
1,418,179
1,417,666
1,288,239
1,097,932
1,097,449
1,119,309
1,119,389
1,119,350
1,120,292
1,120,540
1,122,011
1,121,900
1,154,865
457,578
454,770
478,814
495,901
508,235
504,702
500,585
504,772
198,438
202,059
202,429
199,799
197,561
198,882
196,225
207,420
208,609
227,082
227,524
229,271
230,701
230,321
297,005
289,356
321,077
313,159
317,414
418,245
438,829
434,056
754,925
763,576
787,517
756,022
776,453
800,247
804,906
835,936
1,254,444
1,252,700
1,247,133
1,245,848
1,526,682
1,521,619
1,540,565
1,731,837
1,735,641
1,777,642
1,809,168
1,890,630
2,540,067
2,736,322
2,711,881
2,695,994
2,860,258
2,776,005
2,849,903
2,901,627
2,916,593
2,884,602
3,095,045
3,095,0452,884,6022,916,5932,901,6272,849,9032,776,0052,860,2582,695,9942,711,8812,736,3222,540,0671,890,6301,809,1681,777,6421,735,6411,731,8371,540,5651,521,6191,526,6821,245,8481,247,1331,252,7001,254,444835,936804,906800,247776,453756,022787,517763,576754,925434,056438,829418,245317,414313,159321,077289,356297,005230,321230,701229,271227,524227,082208,609207,420196,225198,882197,561199,799202,429202,059198,438504,772500,585504,702508,235495,901478,814454,770457,5781,154,8651,121,9001,122,0111,120,5401,120,2921,119,3501,119,3891,119,3091,097,4491,097,9321,288,2391,417,6661,418,1791,419,1001,419,7621,422,600115,000113,691114,165105,300103,600104,270105,11896,50078,70087,41670,43052,10090,984041,90041,90040,50041,7000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,047
0
0
0
32,730
0
0
0
45,331
0
0
0
71,101
76,076
91,323
95,837
88,591
100,666
112,240
113,598
122,979
117,064
141,817
164,017
221,804
211,278
213,762
201,195
201,352
198,265
279,071
290,097
311,602
293,787
300,281
301,847
243,811
243,811301,847300,281293,787311,602290,097279,071198,265201,352201,195213,762211,278221,804164,017141,817117,064122,979113,598112,240100,66688,59195,83791,32376,07671,10100045,33100032,73000027,04700000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
42,619
41,658
40,508
41,893
91,529
89,480
0
90,374
20,244
19,691
106,924
130,736
138,264
136,760
134,620
135,723
147,671
145,849
145,984
1,678,880
1,664,533
1,645,579
1,634,209
1,616,814
188,291
164,302
155,279
160,204
159,368
158,442
156,397
148,905
143,184
135,512
152,465
136,100
126,914
153,368
179,131
160,292
151,830
144,025
140,003
121,236
118,950
113,028
105,941
93,437
90,454
84,570
89,777
84,922
95,035
90,210
87,245
84,537
79,451
181,269
167,545
178,875
169,242
172,376
277,686
280,804
265,384
415,196
396,452
394,448
369,813
368,794
375,447
369,762
370,296
649,136
629,733
610,888
594,759
734,701
702,125
689,413
832,863
806,191
802,778
787,599
795,565
1,056,775
1,099,880
1,061,192
1,019,537
1,032,372
968,019
955,275
958,119
929,890
886,286
864,051
864,051886,286929,890958,119955,275968,0191,032,3721,019,5371,061,1921,099,8801,056,775795,565787,599802,778806,191832,863689,413702,125734,701594,759610,888629,733649,136370,296369,762375,447368,794369,813394,448396,452415,196265,384280,804277,686172,376169,242178,875167,545181,26979,45184,53787,24590,21095,03584,92289,77784,57090,45493,437105,941113,028118,950121,236140,003144,025151,830160,292179,131153,368126,914136,100152,465135,512143,184148,905156,397158,442159,368160,204155,279164,302188,2911,616,8141,634,2091,645,5791,664,5331,678,880145,984145,849147,671135,723134,620136,760138,264130,736106,92419,69120,24490,374089,48091,52941,89340,50841,65842,619
       Long-term Assets Other 
128,033
121,963
130,455
131,977
27,882
24,731
25,067
114,915
26,959
24,744
23,788
23,757
22,670
22,694
25,151
27,882
29,089
32,914
35,284
30,088
29,485
27,372
25,714
34,708
21,511
287,488
132,739
134,695
142,654
140,127
123,137
90,180
61,328
64,569
62,722
56,245
55,022
60,937
52,883
55,244
53,661
53,473
64,730
63,145
65,353
56,304
57,053
58,645
48,004
42,331
41,890
43,495
43,760
46,308
44,497
47,204
48,040
63,248
63,547
51,305
39,983
34,075
35,621
38,913
38,160
38,767
40,676
43,099
45,073
46,275
50,287
52,901
60,556
57,947
58,758
55,168
57,339
70,110
79,576
89,636
80,015
82,554
83,521
130,822
138,153
144,032
140,250
151,537
158,387
156,564
139,596
148,279
153,990
155,465
154,876
309,383
309,383154,876155,465153,990148,279139,596156,564158,387151,537140,250144,032138,153130,82283,52182,55480,01589,63679,57670,11057,33955,16858,75857,94760,55652,90150,28746,27545,07343,09940,67638,76738,16038,91335,62134,07539,98351,30563,54763,24848,04047,20444,49746,30843,76043,49541,89042,33148,00458,64557,05356,30465,35363,14564,73053,47353,66155,24452,88360,93755,02256,24562,72264,56961,32890,180123,137140,127142,654134,695132,739287,48821,51134,70825,71427,37229,48530,08835,28432,91429,08927,88225,15122,69422,67023,75723,78824,74426,959114,91525,06724,73127,882131,977130,455121,963128,033
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,804
40,523
43,983
45,917
38,554
29,857
30,187
28,249
35,536
18,711
19,746
21,215
23,193
22,399
22,699
21,026
40,028
26,355
22,954
22,078
28,746
30,306
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000030,30628,74622,07822,95426,35540,02821,02622,69922,39923,19321,21519,74618,71135,53628,24930,18729,85738,55445,91743,98340,52344,80400000000000000000000000000000000000000000000000
> Total Liabilities 
498,624
493,092
282,408
280,351
344,282
296,124
294,410
268,864
363,845
306,958
306,533
325,401
317,099
316,284
323,673
324,755
322,438
333,838
346,813
1,144,538
1,100,240
807,133
794,106
701,478
665,126
967,288
940,544
953,110
923,756
930,791
930,211
941,570
931,228
942,015
948,808
960,471
869,550
870,662
842,358
830,269
803,183
762,620
1,042,105
1,044,646
1,180,289
1,113,261
1,042,346
1,030,957
1,000,853
981,223
967,666
983,144
963,942
959,208
969,736
979,963
931,503
1,164,841
1,143,977
1,180,846
1,150,214
1,150,112
1,296,799
1,302,933
1,290,546
1,901,002
1,802,288
1,858,016
1,803,330
1,791,953
1,825,424
1,865,906
1,841,063
2,664,016
2,522,617
2,517,576
2,505,089
3,146,641
3,017,830
3,026,315
3,522,124
3,460,275
3,287,840
3,347,163
3,592,744
4,366,273
4,593,816
4,432,300
4,404,324
4,836,257
4,710,825
4,579,265
4,542,621
4,472,379
4,256,298
4,536,003
4,536,0034,256,2984,472,3794,542,6214,579,2654,710,8254,836,2574,404,3244,432,3004,593,8164,366,2733,592,7443,347,1633,287,8403,460,2753,522,1243,026,3153,017,8303,146,6412,505,0892,517,5762,522,6172,664,0161,841,0631,865,9061,825,4241,791,9531,803,3301,858,0161,802,2881,901,0021,290,5461,302,9331,296,7991,150,1121,150,2141,180,8461,143,9771,164,841931,503979,963969,736959,208963,942983,144967,666981,2231,000,8531,030,9571,042,3461,113,2611,180,2891,044,6461,042,105762,620803,183830,269842,358870,662869,550960,471948,808942,015931,228941,570930,211930,791923,756953,110940,544967,288665,126701,478794,106807,1331,100,2401,144,538346,813333,838322,438324,755323,673316,284317,099325,401306,533306,958363,845268,864294,410296,124344,282280,351282,408493,092498,624
   > Total Current Liabilities 
83,920
67,078
60,551
64,320
99,300
80,463
86,625
98,532
89,695
102,376
100,899
113,369
103,660
103,073
110,565
114,351
110,714
122,361
136,068
349,115
325,760
316,220
318,250
311,412
268,023
275,123
253,581
259,331
246,290
269,681
290,366
302,528
302,837
500,775
512,510
300,998
279,873
269,645
254,099
249,773
247,218
246,060
237,379
259,780
307,808
277,103
223,842
216,797
223,836
328,126
325,237
342,247
330,812
225,854
235,171
247,034
239,319
271,648
283,083
296,170
270,489
276,532
314,104
311,761
309,989
413,393
412,047
429,593
383,374
424,071
415,755
463,504
407,098
518,140
539,599
558,222
529,759
635,598
681,646
710,181
690,896
727,936
787,014
839,751
803,376
929,610
983,751
1,033,185
993,839
1,048,135
1,014,194
1,091,585
981,392
1,007,623
993,816
1,055,082
1,055,082993,8161,007,623981,3921,091,5851,014,1941,048,135993,8391,033,185983,751929,610803,376839,751787,014727,936690,896710,181681,646635,598529,759558,222539,599518,140407,098463,504415,755424,071383,374429,593412,047413,393309,989311,761314,104276,532270,489296,170283,083271,648239,319247,034235,171225,854330,812342,247325,237328,126223,836216,797223,842277,103307,808259,780237,379246,060247,218249,773254,099269,645279,873300,998512,510500,775302,837302,528290,366269,681246,290259,331253,581275,123268,023311,412318,250316,220325,760349,115136,068122,361110,714114,351110,565103,073103,660113,369100,899102,37689,69598,53286,62580,46399,30064,32060,55167,07883,920
       Short-term Debt 
7,678
6,653
313
412
17,786
849
992
933
3,132
62,879
9,664
0
61,124
59,714
28,196
60,983
57,597
496
67,809
80,865
80,868
80,868
80,555
36,445
36,403
36,724
24,116
24,977
25,759
24,098
24,133
25,051
33,743
210,042
239,030
35,452
35,376
35,404
34,594
35,413
36,343
26,774
17,816
30,582
95,527
57,994
19,838
14,758
29,575
134,830
125,603
139,384
130,851
16,163
16,170
21,437
26,683
31,932
31,917
31,904
31,880
17,993
16,599
17,033
21,382
33,939
25,970
27,313
27,308
27,225
27,090
30,998
3,137
31,346
31,651
31,416
49,567
53,360
53,643
38,545
70,136
78,163
72,816
50,214
28,800
3,021
34,006
2,795
40,400
2,364
46,692
50,203
6,819
411,506
422,245
441,115
441,115422,245411,5066,81950,20346,6922,36440,4002,79534,0063,02128,80050,21472,81678,16370,13638,54553,64353,36049,56731,41631,65131,3463,13730,99827,09027,22527,30827,31325,97033,93921,38217,03316,59917,99331,88031,90431,91731,93226,68321,43716,17016,163130,851139,384125,603134,83029,57514,75819,83857,99495,52730,58217,81626,77436,34335,41334,59435,40435,37635,452239,030210,04233,74325,05124,13324,09825,75924,97724,11636,72436,40336,44580,55580,86880,86880,86567,80949657,59760,98328,19659,71461,12409,66462,8793,13293399284917,7864123136,6537,678
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,714
0
0
0
15,193
21,382
33,939
25,970
24,560
27,308
1,143,503
24,481
28,546
111
28,230
28,229
28,228
28,225
30,708
30,609
35,548
44,738
50,505
45,017
47,196
109
108
105
101
99
2,364
0
0
0
0
0
0
0000002,3649910110510810947,19645,01750,50544,73835,54830,60930,70828,22528,22828,22928,23011128,54624,4811,143,50327,30824,56025,97033,93921,38215,19300031,71400000000000000000000000000000000000000000000000000000000000
       Accounts payable 
9,770
8,693
7,968
10,767
10,814
9,501
9,408
13,868
11,777
12,240
10,917
13,084
12,585
12,765
12,450
19,433
16,227
16,451
15,487
28,672
26,397
24,347
25,753
30,447
34,133
26,813
23,681
28,223
37,256
35,707
36,013
36,715
36,772
43,523
36,367
40,517
37,280
36,568
35,843
31,232
33,508
29,681
33,067
30,627
33,379
33,092
34,622
34,332
32,353
34,487
27,744
31,218
31,277
37,295
29,675
31,770
35,253
35,218
27,547
33,815
34,904
32,967
31,629
36,675
43,897
66,198
65,809
68,485
60,987
64,652
66,232
77,838
73,479
67,481
77,736
66,250
78,523
99,381
107,231
111,498
102,697
82,978
96,758
122,475
127,129
110,926
127,913
198,130
225,977
211,381
181,629
205,915
120,004
140,204
136,341
168,937
168,937136,341140,204120,004205,915181,629211,381225,977198,130127,913110,926127,129122,47596,75882,978102,697111,498107,23199,38178,52366,25077,73667,48173,47977,83866,23264,65260,98768,48565,80966,19843,89736,67531,62932,96734,90433,81527,54735,21835,25331,77029,67537,29531,27731,21827,74434,48732,35334,33234,62233,09233,37930,62733,06729,68133,50831,23235,84336,56837,28040,51736,36743,52336,77236,71536,01335,70737,25628,22323,68126,81334,13330,44725,75324,34726,39728,67215,48716,45116,22719,43312,45012,76512,58513,08410,91712,24011,77713,8689,4089,50110,81410,7677,9688,6939,770
       Other Current Liabilities 
66,472
51,732
52,270
53,141
58,940
54,160
59,439
61,521
51,626
5,089
58,256
100,285
6,322
5,597
44,671
3,089
3,791
71,811
15,451
122,088
110,039
107,155
114,597
128,218
97,108
129,234
126,843
112,934
94,749
114,913
141,773
138,741
134,766
152,321
151,643
138,322
123,528
122,743
110,246
110,738
109,554
127,954
124,351
131,666
120,070
126,972
114,812
111,177
103,713
97,816
114,057
115,223
115,497
118,701
133,969
139,650
122,961
142,628
156,699
152,327
127,047
148,190
189,857
176,710
164,413
194,419
200,970
206,064
167,488
212,858
213,449
237,099
208,443
251,377
244,866
315,417
231,403
282,404
318,671
388,333
301,915
355,220
402,114
459,120
397,763
584,334
551,568
612,557
435,217
592,306
457,496
571,208
592,343
198,517
184,745
203,210
203,210184,745198,517592,343571,208457,496592,306435,217612,557551,568584,334397,763459,120402,114355,220301,915388,333318,671282,404231,403315,417244,866251,377208,443237,099213,449212,858167,488206,064200,970194,419164,413176,710189,857148,190127,047152,327156,699142,628122,961139,650133,969118,701115,497115,223114,05797,816103,713111,177114,812126,972120,070131,666124,351127,954109,554110,738110,246122,743123,528138,322151,643152,321134,766138,741141,773114,91394,749112,934126,843129,23497,108128,218114,597107,155110,039122,08815,45171,8113,7913,08944,6715,5976,322100,28558,2565,08951,62661,52159,43954,16058,94053,14152,27051,73266,472
   > Long-term Liabilities 
414,704
426,014
221,857
216,031
244,982
215,661
207,785
170,332
274,150
204,582
205,634
212,032
213,439
213,211
213,108
210,404
211,724
211,477
210,745
795,423
774,480
490,913
475,856
390,066
397,103
692,165
686,963
693,779
677,466
661,110
639,845
639,042
628,391
441,240
436,298
659,473
589,677
601,017
588,259
580,496
555,965
516,560
804,726
784,866
872,481
836,158
818,504
814,160
777,017
653,097
642,429
640,897
633,130
733,354
734,565
732,929
692,184
893,193
860,894
884,676
879,725
873,580
982,695
991,172
980,557
1,487,609
1,390,241
1,428,423
1,419,956
1,367,882
1,409,669
1,402,402
1,433,965
2,145,876
1,983,018
1,959,354
1,975,330
2,511,043
2,336,184
2,316,134
2,831,228
2,732,339
2,500,826
2,507,412
2,789,368
3,436,663
3,610,065
3,399,115
3,410,485
3,788,122
3,696,631
3,487,680
3,561,229
3,464,756
3,262,482
3,480,921
3,480,9213,262,4823,464,7563,561,2293,487,6803,696,6313,788,1223,410,4853,399,1153,610,0653,436,6632,789,3682,507,4122,500,8262,732,3392,831,2282,316,1342,336,1842,511,0431,975,3301,959,3541,983,0182,145,8761,433,9651,402,4021,409,6691,367,8821,419,9561,428,4231,390,2411,487,609980,557991,172982,695873,580879,725884,676860,894893,193692,184732,929734,565733,354633,130640,897642,429653,097777,017814,160818,504836,158872,481784,866804,726516,560555,965580,496588,259601,017589,677659,473436,298441,240628,391639,042639,845661,110677,466693,779686,963692,165397,103390,066475,856490,913774,480795,423210,745211,477211,724210,404213,108213,211213,439212,032205,634204,582274,150170,332207,785215,661244,982216,031221,857426,014414,704
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
409,441
701,075
670,270
761,293
731,418
720,483
703,187
674,743
551,397
543,143
527,136
518,035
619,771
624,310
642,352
614,129
781,617
754,799
745,958
754,533
754,777
835,800
845,997
840,481
1,331,053
1,233,189
1,207,696
1,170,063
1,116,278
1,155,998
1,114,105
1,129,581
1,796,451
1,652,733
1,636,598
1,540,833
2,040,388
1,882,593
1,849,666
2,326,770
2,207,157
1,968,161
1,929,571
2,202,334
2,727,240
2,892,676
2,663,564
2,676,165
2,997,221
2,937,056
2,707,531
2,743,774
2,678,472
2,514,217
0
02,514,2172,678,4722,743,7742,707,5312,937,0562,997,2212,676,1652,663,5642,892,6762,727,2402,202,3341,929,5711,968,1612,207,1572,326,7701,849,6661,882,5932,040,3881,540,8331,636,5981,652,7331,796,4511,129,5811,114,1051,155,9981,116,2781,170,0631,207,6961,233,1891,331,053840,481845,997835,800754,777754,533745,958754,799781,617614,129642,352624,310619,771518,035527,136543,143551,397674,743703,187720,483731,418761,293670,270701,075409,44100000000000000000000000000000000000000000
       Long term Debt 
390,464
393,363
202,780
202,500
230,705
201,708
193,654
155,867
259,524
189,048
188,588
192,484
189,761
189,868
189,760
185,683
186,229
186,137
185,961
605,980
585,772
325,677
297,728
260,217
270,652
571,808
576,542
547,084
527,555
511,816
493,697
484,998
476,367
312,260
303,681
540,646
474,152
486,487
463,748
457,419
437,911
409,441
701,075
670,270
761,293
731,418
720,483
703,187
674,743
551,397
543,143
527,136
518,035
619,771
624,310
642,352
614,129
781,617
754,799
745,958
754,533
754,777
835,800
845,997
840,481
1,331,053
1,233,189
1,207,696
1,170,063
1,116,278
1,155,998
1,114,105
1,101,267
1,768,935
1,625,350
1,610,546
1,514,324
2,012,124
1,855,883
1,822,136
2,300,891
2,182,482
1,943,307
1,903,542
2,176,313
2,701,000
2,866,859
2,639,035
2,652,753
2,997,221
2,937,056
2,707,531
2,743,774
2,678,472
2,514,217
2,647,147
2,647,1472,514,2172,678,4722,743,7742,707,5312,937,0562,997,2212,652,7532,639,0352,866,8592,701,0002,176,3131,903,5421,943,3072,182,4822,300,8911,822,1361,855,8832,012,1241,514,3241,610,5461,625,3501,768,9351,101,2671,114,1051,155,9981,116,2781,170,0631,207,6961,233,1891,331,053840,481845,997835,800754,777754,533745,958754,799781,617614,129642,352624,310619,771518,035527,136543,143551,397674,743703,187720,483731,418761,293670,270701,075409,441437,911457,419463,748486,487474,152540,646303,681312,260476,367484,998493,697511,816527,555547,084576,542571,808270,652260,217297,728325,677585,772605,980185,961186,137186,229185,683189,760189,868189,761192,484188,588189,048259,524155,867193,654201,708230,705202,500202,780393,363390,464
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
156,905
159,227
166,612
167,136
184,717
199,681
199,231
209,316
227,727
300,378
303,730
316,156
328,069
365,775
442,892
389,745
418,202
401,628
390,437
419,234
419,234390,437401,628418,202389,745442,892365,775328,069316,156303,730300,378227,727209,316199,231199,681184,717167,136166,612159,227156,9050000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,804
40,523
43,983
45,917
38,554
29,857
30,187
28,249
35,536
18,711
19,746
21,215
23,193
22,399
22,699
21,026
40,028
26,355
22,954
22,078
28,746
30,306
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000030,30628,74622,07822,95426,35540,02821,02622,69922,39923,19321,21519,74618,71135,53628,24930,18729,85738,55445,91743,98340,52344,80400000000000000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,038
11,676
14,577
20,581
21,579
23,483
24,550
28,419
29,453
29,976
27,447
28,008
28,744
25,824
15,040
14,659
14,698
15,317
15,785
16,609
17,323
16,662
17,331
18,525
20,519
20,479
28,345
28,647
24,039
23,884
24,033
25,499
28,035
30,799
32,556
53,010
55,819
40,177
39,206
42,427
42,935
42,447
0
0
0042,44742,93542,42739,20640,17755,81953,01032,55630,79928,03525,49924,03323,88424,03928,64728,34520,47920,51918,52517,33116,66217,32316,60915,78515,31714,69814,65915,04025,82428,74428,00827,44729,97629,45328,41924,55023,48321,57920,58114,57711,6769,0380000000000000000000000000000000000000000000000000000
       Other Liabilities 
3,706
12,489
12,251
13,531
14,277
13,953
14,131
14,465
14,626
15,534
17,046
19,548
23,678
23,343
23,348
24,721
21,323
21,433
20,877
96,300
97,562
92,552
90,939
86,147
85,935
89,715
81,661
90,323
91,344
92,447
92,641
83,130
82,731
62,748
61,084
71,289
71,490
68,375
76,222
80,210
77,787
68,293
64,745
84,546
82,213
83,285
80,088
94,899
88,673
86,284
85,018
100,614
98,932
97,433
93,725
75,589
63,215
77,147
75,331
107,902
93,507
93,253
97,879
96,952
94,779
103,313
102,984
165,010
165,963
168,648
171,888
198,757
304,384
349,425
330,285
322,756
325,443
362,344
336,723
350,216
371,018
377,834
386,087
422,246
414,019
469,939
473,377
482,579
469,964
425,126
390,724
390,404
0
384,656
357,828
0
0357,828384,6560390,404390,724425,126469,964482,579473,377469,939414,019422,246386,087377,834371,018350,216336,723362,344325,443322,756330,285349,425304,384198,757171,888168,648165,963165,010102,984103,31394,77996,95297,87993,25393,507107,90275,33177,14763,21575,58993,72597,43398,932100,61485,01886,28488,67394,89980,08883,28582,21384,54664,74568,29377,78780,21076,22268,37571,49071,28961,08462,74882,73183,13092,64192,44791,34490,32381,66189,71585,93586,14790,93992,55297,56296,30020,87721,43321,32324,72123,34823,34323,67819,54817,04615,53414,62614,46514,13113,95314,27713,53112,25112,4893,706
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
107,119
103,651
114,596
111,188
106,277
99,679
110,973
102,275
101,700
99,286
113,761
115,095
113,583
110,255
90,577
78,055
111,576
106,095
138,718
125,192
118,803
146,895
96,952
94,779
103,313
102,984
165,010
165,963
168,648
171,888
198,757
208,347
196,640
184,954
179,121
282,616
288,900
288,111
299,185
307,364
323,390
330,273
360,810
380,023
70,843
458,270
495,831
503,371
560,850
563,561
564,567
605,177
177,252
172,518
223,191
223,191172,518177,252605,177564,567563,561560,850503,371495,831458,27070,843380,023360,810330,273323,390307,364299,185288,111288,900282,616179,121184,954196,640208,347198,757171,888168,648165,963165,010102,984103,31394,77996,952146,895118,803125,192138,718106,095111,57678,05590,577110,255113,583115,095113,76199,286101,700102,275110,97399,679106,277111,188114,596103,651107,11900000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,223
45,297
53,243
54,068
55,717
83,930
82,956
81,783
89,540
96,037
152,785
145,331
143,635
151,881
181,755
165,480
167,283
197,094
201,792
202,392
217,031
207,011
262,562
259,119
239,720
230,949
230,051
196,014
215,582
212,278
207,404
0
0
00207,404212,278215,582196,014230,051230,949239,720259,119262,562207,011217,031202,392201,792197,094167,283165,480181,755151,881143,635145,331152,78596,03789,54081,78382,95683,93055,71754,06853,24345,29748,223000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
-111,173
-108,663
113,094
116,927
199,141
208,218
277,667
289,510
288,406
309,536
332,840
357,376
380,346
411,704
431,940
464,623
493,999
519,062
550,824
1,472,505
1,517,791
1,731,683
1,785,648
1,827,013
1,737,055
1,640,990
1,553,522
1,595,211
1,642,218
1,729,868
1,802,096
1,860,467
1,910,026
1,945,875
1,947,294
1,199,025
1,218,154
1,282,956
1,349,174
1,375,243
1,383,688
1,394,017
1,040,972
687,423
562,918
590,627
541,369
525,583
552,599
562,836
597,713
600,805
628,279
647,951
656,508
640,984
695,462
671,815
670,296
672,203
663,713
701,703
704,359
733,067
779,824
831,348
867,969
836,768
876,431
963,496
1,021,513
1,045,080
1,139,826
1,181,966
1,253,106
1,317,332
1,398,114
1,455,066
1,532,313
1,634,584
1,651,984
1,752,641
1,896,940
2,114,602
2,183,927
2,318,440
2,426,566
2,534,820
2,610,184
2,647,706
2,626,853
2,976,293
3,108,597
3,251,703
3,305,993
3,596,882
3,596,8823,305,9933,251,7033,108,5972,976,2932,626,8532,647,7062,610,1842,534,8202,426,5662,318,4402,183,9272,114,6021,896,9401,752,6411,651,9841,634,5841,532,3131,455,0661,398,1141,317,3321,253,1061,181,9661,139,8261,045,0801,021,513963,496876,431836,768867,969831,348779,824733,067704,359701,703663,713672,203670,296671,815695,462640,984656,508647,951628,279600,805597,713562,836552,599525,583541,369590,627562,918687,4231,040,9721,394,0171,383,6881,375,2431,349,1741,282,9561,218,1541,199,0251,947,2941,945,8751,910,0261,860,4671,802,0961,729,8681,642,2181,595,2111,553,5221,640,9901,737,0551,827,0131,785,6481,731,6831,517,7911,472,505550,824519,062493,999464,623431,940411,704380,346357,376332,840309,536288,406289,510277,667208,218199,141116,927113,094-108,663-111,173
   Common Stock
103
198
359
359
401
402
440
442
445
447
451
452
453
456
458
458
461
462
463
658
666
717
723
724
729
730
733
734
739
747
751
754
760
762
766
766
771
771
771
771
775
776
775
775
780
783
785
785
790
791
794
796
807
810
817
825
836
836
839
845
853
853
854
855
861
862
863
863
871
873
874
875
881
882
883
482
489
489
490
489
496
498
499
498
504
505
506
505
509
510
510
509
512
513
514
513
513514513512509510510509505506505504498499498496489490489489482883882881875874873871863863862861855854853853845839836836825817810807796794791790785785783780775775776775771771771771766766762760754751747739734733730729724723717666658463462461458458456453452451447445442440402401359359198103
   Retained Earnings 
-306,715
-298,741
-323,003
-318,575
-311,624
-302,605
-292,085
-283,168
-285,400
-269,072
-250,541
-233,036
-213,682
-193,121
-173,530
-152,885
-135,291
-108,991
-83,170
-63,093
-35,445
-3,585
28,488
78,906
-21,209
4,540
-12,066
23,123
59,886
97,842
140,619
177,529
222,683
272,870
317,570
-344,314
-327,531
-293,375
-256,062
-238,493
-221,111
-206,657
-231,598
-575,162
-543,827
-511,509
-492,711
-465,596
-439,157
-408,689
-386,717
-368,301
-342,723
-315,439
-284,572
-265,473
-233,241
-197,977
-165,941
-138,775
-107,234
-58,725
-21,346
10,538
47,681
82,888
120,623
165,303
212,081
266,033
318,507
288,658
346,044
399,752
460,120
42,096
97,229
140,957
213,767
280,329
331,098
398,533
501,442
625,414
686,944
775,392
878,818
980,751
1,073,773
1,183,094
1,279,567
1,432,901
1,536,032
1,633,052
1,720,441
1,887,218
1,887,2181,720,4411,633,0521,536,0321,432,9011,279,5671,183,0941,073,773980,751878,818775,392686,944625,414501,442398,533331,098280,329213,767140,95797,22942,096460,120399,752346,044288,658318,507266,033212,081165,303120,62382,88847,68110,538-21,346-58,725-107,234-138,775-165,941-197,977-233,241-265,473-284,572-315,439-342,723-368,301-386,717-408,689-439,157-465,596-492,711-511,509-543,827-575,162-231,598-206,657-221,111-238,493-256,062-293,375-327,531-344,314317,570272,870222,683177,529140,61997,84259,88623,123-12,0664,540-21,20978,90628,488-3,585-35,445-63,093-83,170-108,991-135,291-152,885-173,530-193,121-213,682-233,036-250,541-269,072-285,400-283,168-292,085-302,605-311,624-318,575-323,003-298,741-306,715
   Accumulated Other Comprehensive Income 
-11,596
-12,523
-15,666
-16,261
-19,595
-20,169
-16,448
-16,673
-17,245
-14,447
-16,156
-11,768
-9,223
-1,129
-3,960
7,269
10,101
5,414
7,972
16,086
-443
-24,005
-14,605
-12,245
10,373
28,914
23,221
21,171
25,629
42,341
71,228
85,559
97,881
101,253
70,908
3,347
-19,240
20,188
43,553
45,037
33,276
20,200
36,254
33,635
41,855
39,128
25,979
4,593
12,676
2,193
15,564
6,603
-13,533
-19,308
-1,957
5,357
1,084
14,211
-17,654
-74,247
-108,745
-90,363
-120,800
-135,548
-142,817
-150,192
-165,746
-253,764
-242,032
-208,327
-183,312
-144,731
-124,457
-153,608
-159,448
-172,703
-162,800
-166,236
-178,470
-178,019
-218,917
-212,714
-195,281
-138,874
-127,017
-108,021
-132,779
-164,740
-174,933
-258,555
-395,608
-262,057
-239,124
-208,269
-268,066
-196,427
-196,427-268,066-208,269-239,124-262,057-395,608-258,555-174,933-164,740-132,779-108,021-127,017-138,874-195,281-212,714-218,917-178,019-178,470-166,236-162,800-172,703-159,448-153,608-124,457-144,731-183,312-208,327-242,032-253,764-165,746-150,192-142,817-135,548-120,800-90,363-108,745-74,247-17,65414,2111,0845,357-1,957-19,308-13,5336,60315,5642,19312,6764,59325,97939,12841,85533,63536,25420,20033,27645,03743,55320,188-19,2403,34770,908101,25397,88185,55971,22842,34125,62921,17123,22128,91410,373-12,245-14,605-24,005-44316,0867,9725,41410,1017,269-3,960-1,129-9,223-11,768-16,156-14,447-17,245-16,673-16,448-20,169-19,595-16,261-15,666-12,523-11,596
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,055,641
1,961,066
1,996,874
2,025,643
2,043,011
2,051,777
2,056,921
2,064,890
2,070,474
2,085,034
2,097,316
2,130,266
2,145,054
2,170,901
2,206,155
2,249,137
2,257,597
2,276,279
2,307,640
2,360,731
2,372,685
2,386,342
2,397,960
2,426,984
2,450,726
2,465,193
2,477,371
2,506,696
2,528,742
2,545,351
2,560,192
2,590,821
2,608,522
2,625,256
1,447,512
1,481,011
1,497,794
1,514,620
1,531,785
1,562,982
1,590,117
1,614,185
1,627,564
1,659,524
1,690,861
1,720,461
1,718,304
1,744,829
1,761,125
1,780,876
1,804,940
1,830,189
1,850,385
1,877,120
0
01,877,1201,850,3851,830,1891,804,9401,780,8761,761,1251,744,8291,718,3041,720,4611,690,8611,659,5241,627,5641,614,1851,590,1171,562,9821,531,7851,514,6201,497,7941,481,0111,447,5122,625,2562,608,5222,590,8212,560,1922,545,3512,528,7422,506,6962,477,3712,465,1932,450,7262,426,9842,397,9602,386,3422,372,6852,360,7312,307,6402,276,2792,257,5972,249,1372,206,1552,170,9012,145,0542,130,2662,097,3162,085,0342,070,4742,064,8902,056,9212,051,7772,043,0112,025,6431,996,8741,961,0662,055,64100000000000000000000000000000000000000000
   Treasury Stock00-23,978-19,0120-38,492-38,468-33,9940-40,440-40,297-36,0280-23,905-23,793-23,6750-18,094-17,938-17,815-55-1,673,705-1,673,582-1,673,463-1,659,914-1,659,907-1,623,825-1,601,185-1,553,005-1,552,964-1,552,936-1,552,885-1,540,738-1,540,691-1,522,747-1,481,892-1,423,260-1,423,227-1,402,852-1,322,354-1,305,880-1,228,681-1,163,166-1,146,538-1,135,609-1,116,962-1,101,933-1,086,600-1,071,120-1,046,119-982,323-961,533-768,699-725,525-473,492-473,422-470,527-470,400-469,794-455,714-425,924-401,132-368,985-335,943-310,372-298,269-276,930-274,249-267,955-264,600-189,423-31,763-17,997-3,1150000000000000000000000
   Other Stockholders Equity 
207,035
202,403
451,404
451,404
529,959
530,590
585,760
588,909
590,606
592,608
599,086
601,728
602,798
605,498
608,972
609,781
618,728
622,177
625,559
1,518,854
1,553,013
1,758,556
1,771,042
1,759,628
1,747,162
1,606,806
1,541,634
1,550,183
1,555,964
1,588,938
1,589,498
1,596,625
1,588,702
1,570,990
1,558,050
1,539,226
1,564,154
1,555,372
1,560,912
1,567,928
1,570,748
1,579,698
1,235,541
1,228,175
1,064,110
1,062,225
1,007,316
985,801
978,290
968,541
968,072
961,707
983,728
981,888
942,220
900,275
926,783
854,745
853,052
884,380
878,839
849,938
845,651
857,222
874,099
897,790
912,229
924,366
905,511
904,917
885,444
900,278
917,358
934,940
951,551
1,447,457
1,463,196
1,479,856
1,496,526
1,531,785
1,539,307
1,566,324
1,590,280
1,627,564
1,623,496
1,650,564
1,680,021
1,718,304
1,710,835
1,722,657
1,742,384
1,804,940
1,811,177
1,826,407
1,853,104
1,905,578
1,905,5781,853,1041,826,4071,811,1771,804,9401,742,3841,722,6571,710,8351,718,3041,680,0211,650,5641,623,4961,627,5641,590,2801,566,3241,539,3071,531,7851,496,5261,479,8561,463,1961,447,457951,551934,940917,358900,278885,444904,917905,511924,366912,229897,790874,099857,222845,651849,938878,839884,380853,052854,745926,783900,275942,220981,888983,728961,707968,072968,541978,290985,8011,007,3161,062,2251,064,1101,228,1751,235,5411,579,6981,570,7481,567,9281,560,9121,555,3721,564,1541,539,2261,558,0501,570,9901,588,7021,596,6251,589,4981,588,9381,555,9641,550,1831,541,6341,606,8061,747,1621,759,6281,771,0421,758,5561,553,0131,518,854625,559622,177618,728609,781608,972605,498602,798601,728599,086592,608590,606588,909585,760530,590529,959451,404451,404202,403207,035



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,129,409
Cost of Revenue-2,626,853
Gross Profit1,502,5561,502,556
 
Operating Income (+$)
Gross Profit1,502,556
Operating Expense-885,295
Operating Income617,261617,261
 
Operating Expense (+$)
Research Development0
Selling General Administrative750,353
Selling And Marketing Expenses0
Operating Expense885,295750,353
 
Net Interest Income (+$)
Interest Income3,948
Interest Expense-136,710
Other Finance Cost-1,235
Net Interest Income-133,997
 
Pretax Income (+$)
Operating Income617,261
Net Interest Income-133,997
Other Non-Operating Income Expenses0
Income Before Tax (EBT)581,284521,724
EBIT - interestExpense = 581,284
575,538
611,334
Interest Expense136,710
Earnings Before Interest and Taxes (EBIT)717,994717,994
Earnings Before Interest and Taxes (EBITDA)1,032,118
 
After tax Income (+$)
Income Before Tax581,284
Tax Provision-136,975
Net Income From Continuing Ops480,524444,309
Net Income474,624
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,512,148
Total Other Income/Expenses Net95,537133,997
 

Technical Analysis of Charles River Laboratories
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Charles River Laboratories. The general trend of Charles River Laboratories is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Charles River Laboratories's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Charles River Laboratories.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 274.77 < 275.00.

The bearish price targets are: 201.01 > 197.67 > 166.87.

Tweet this
Charles River Laboratories Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Charles River Laboratories. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Charles River Laboratories Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Charles River Laboratories. The current macd is -6.68805206.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Charles River Laboratories price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Charles River Laboratories. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Charles River Laboratories price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Charles River Laboratories Daily Moving Average Convergence/Divergence (MACD) ChartCharles River Laboratories Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Charles River Laboratories. The current adx is 31.80.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Charles River Laboratories shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Charles River Laboratories Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Charles River Laboratories. The current sar is 246.95.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Charles River Laboratories Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Charles River Laboratories. The current rsi is 26.95. The current phase is Oversold in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bull market: Short-term excessive selling, potential for rebound. Consider buying at a perceived discount, watch for reversal signs. +1
  • Trending down: The RSI is trending down. -1
Charles River Laboratories Daily Relative Strength Index (RSI) ChartCharles River Laboratories Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Charles River Laboratories. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Charles River Laboratories price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Charles River Laboratories Daily Stochastic Oscillator ChartCharles River Laboratories Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Charles River Laboratories. The current cci is -152.12629512.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Charles River Laboratories Daily Commodity Channel Index (CCI) ChartCharles River Laboratories Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Charles River Laboratories. The current cmo is -64.44437557.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Charles River Laboratories Daily Chande Momentum Oscillator (CMO) ChartCharles River Laboratories Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Charles River Laboratories. The current willr is -91.85148018.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Charles River Laboratories Daily Williams %R ChartCharles River Laboratories Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Charles River Laboratories.

Charles River Laboratories Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Charles River Laboratories. The current atr is 6.98154426.

Charles River Laboratories Daily Average True Range (ATR) ChartCharles River Laboratories Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Charles River Laboratories. The current obv is -7,197,063.

Charles River Laboratories Daily On-Balance Volume (OBV) ChartCharles River Laboratories Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Charles River Laboratories. The current mfi is 11.88.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Charles River Laboratories Daily Money Flow Index (MFI) ChartCharles River Laboratories Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Charles River Laboratories.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Charles River Laboratories Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Charles River Laboratories based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.954
Ma 20Greater thanMa 50254.211
Ma 50Greater thanMa 100252.066
Ma 100Greater thanMa 200234.383
OpenGreater thanClose228.020
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Charles River Laboratories with someone you think should read this too:
  • Are you bullish or bearish on Charles River Laboratories? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Charles River Laboratories? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Charles River Laboratories

I send you an email if I find something interesting about Charles River Laboratories.


Comments

How you think about this?

Leave a comment

Stay informed about Charles River Laboratories.

Receive notifications about Charles River Laboratories in your mailbox!